KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Preferred Shares Issued (2020)

Historic Preferred Shares Issued for AbCellera Biologics (ABCL) over the last 1 years, with Q4 2020 value amounting to -$1000.0.

  • AbCellera Biologics' Preferred Shares Issued changed N/A to -$1000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $74.7 million, marking a year-over-year change of. This contributed to the annual value of $74.7 million for FY2020, which is 67884545.45% up from last year.
  • Per AbCellera Biologics' latest filing, its Preferred Shares Issued stood at -$1000.0 for Q4 2020.
  • In the past 5 years, AbCellera Biologics' Preferred Shares Issued registered a high of $74.7 million during Q1 2020, and its lowest value of -$19000.0 during Q3 2020.